Modified FLOT Beats FOLFOX for Advanced Gastric Cancer

TribeNews
0 Min Read

MedPage Today) — A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the first-line treatment of advanced HER2-negative gastric cancer, a phase III trial showed.
In the more…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app